Browsing by Author Goldhirsch, Aron

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 12 of 12
Issue DateTitleAuthor(s)Citation
2016Adjuvant lapatinib and trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer: Results From the randomized phase III adjuvant lapatinib and/or trastuzumab treatment optimization trialBoyle, Frances; Amour, Alison; Baselga, Jose; De Azambuja, Evandro; Dueck, Amylou C.; et al, .; Goldhirsch, Aron; Holmes, Eileen; Piccart-Gebhart, Martine; Pritchard, Kathleen; Viale, Giuseppe; Zujewski, Jo Anne; Northern Clinical School: MedicineAdjuvant lapatinib and trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer: Results From the randomized phase III adjuvant lapatinib and/or trastuzumab treatment optimization trial, Journal of Clinical Oncology, vol.34, 10, 2016,pp 1034-1042
2016Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: Results from the international breast cancer study group trials I to VCoates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; Forbes, John F.; Gelber, Richard; Gianni, Lorenzo; Goldhirsch, Aron; Karlsson, Per; Price, Karen; Sun, Zhuoxin; Thurlimann, B.; School of Public Health: Public HealthAnnual hazard rates of recurrence for breast cancer during 24 years of follow-up: Results from the international breast cancer study group trials I to V, Journal of Clinical Oncology, vol.34, 9, 2016,pp 927-935
2011Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8.1 years median follow-upCoates, Alan; Ejlertsen, Bent; Forbes, John F.; Gelber, Richard; Giobbie-Hurder, Anita; Goldhirsch, Aron; Lang, Istvan; Mauriac, Louis; Neven, Patrick; Price, Karen N.; Rabaglio, Manuela; Regan, Meredith M.; Smith, Ian (Prof); Thurlimann, B.; Wardley, Andrew; School of Public Health: Public HealthAssessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8.1 years median follow-up, Lancet Oncology, vol.12, 12, 2011,pp 1101-1108
2008Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical TrialsCoates, Alan; Castiglione-Gertsch, Monica; Gelber, Richard D. (Prof); Goldhirsch, Aron; Gusterson, Barry A.; Holmberg, Stig B.; Lindtner, Jurii; Mallon, Elizabeth; Murray, E.; Pestalozzi, B. C.; Price, Karen N.; Snyder, Raymond; Thurlimann, Beat; Viale, Giuseppe; Zahrieh, David; School of Public Health: Public HealthDistinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials, Journal of Clinical Oncology, vol.26, 18, 2008,pp 3006-3014
2008Lack of prognostic significance of ‘‘classic’’ lobular breast carcinoma: a matched, single institution seriesCoates, Alan; Colleoni, Marco; Galimberti, Viviana; Goldhirsch, Aron; Luini, Alberto; Maiorano, Eugenio; Maisonneuve, Patrick; Orvieto, Enrico; Rotmensz, N; Viale, Giuseppe; School of Public Health: Public HealthLack of prognostic significance of ‘‘classic’’ lobular breast carcinoma: a matched, single institution series, Breast Cancer Research and Treatment, vol.117,(1),2008,pp 211-214
2008Letrozole Compared With Tamoxifen for Elderly Patients With Endocrine-Responsive Early Breast Cancer: The BIG 1-98 TrialCoates, Alan; Castiglione-Gertsch, Monica; Chirgwin, Jacquie H; Colleoni, Marco; Crivellari, Diana; Del Mastro, Lucia; Forbes, John F.; Gelber, Richard D. (Prof); Gladieff, Laurence; Goldhirsch, Aron; Lang, Istvan; Mauriac, Louis; Mouridsen, Henning; Paridaens, Robert; Price, Karen; Rabaglio, Manuela; Smith, Ian (Prof); Sun, Zhuoxin; Thurlimann, Beat; School of Public Health: Public HealthLetrozole Compared With Tamoxifen for Elderly Patients With Endocrine-Responsive Early Breast Cancer: The BIG 1-98 Trial, Journal of Clinical Oncology, vol.26, 12, 2008,pp 1972-1979
2009Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.Coates, Alan; et al, various; Forbes, John F.; Giobbie-Hurder, Anita; Goldhirsch, Aron; Mauriac, Louis; Mouridsen, Henning; Paridaens, Robert; Price, Karen; Smith, Ian (Prof); Thurlimann, Beat; School of Public Health: Public HealthLetrozole therapy alone or in sequence with tamoxifen in women with breast cancer., New England Journal of Medicine, vol.361, 8,pp 766-776
2008p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer.Coates, Alan; Castiglione-Gertsch, Monica; Gianni, Lorenzo; Goldhirsch, Aron; Gusterson, Barry; Maffini, Fausto; Mastropasqua, M; Monti, F; Panzini, Ilaria; Price, Karen; Ravaioli, A; Regan, Meredith M.; Spataro, Vito J.; Viale, Giuseppe; School of Public Health: Public Healthp27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer., Annals of Oncology, vol.19, 4, 2008,pp 660-668
2012Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trialsCoates, Alan; Gelber, Richard D. (Prof); Gelber, S.; Goldhirsch, Aron; Huober, J; Ohlschlegel, Christian; Price, K. N; Regan, Meredith M.; Thurlimann, Beat; Viale, Giuseppe; School of Public Health: Public HealthPrognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials, Annals of Oncology, vol.23, 11, 2012,pp 2843-2851
2015Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 TrialCoates, Alan; Colleoni, Marco; Debled, Marc; Ejlertsen, Bent; Filho, Otto Metzger; Gelber, Richard; Giobbie-Hurder, Anita; Goldhirsch, Aron; Gusterson, B. A.; Mallon, Elizabeth; Price, Karen N; Regan, Meredith; Thurlimann, Beat; Viale, Giuseppe; Winer, Eric P.; School of Public Health: Public HealthRelative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial, Journal of Clinical Oncology, vol.33, 25, 2015,pp 2772-2779
2011Strategies for subtypes-dealing with the diversity of breast cancer: Highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011Coates, Alan; Gelber, Richard D. (Prof); Goldhirsch, Aron; Senn, H.-J.; Thurlimann, B.; Wood, W. C.; School of Public Health: Public HealthStrategies for subtypes-dealing with the diversity of breast cancer: Highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011, Annals of Oncology, vol.22, 8, 2011,pp 1736-1747
2016Treatment adherence and its impact on disease-free survival in the breast international group 1-98 trial of tamoxifen and letrozole, alone and in sequenceCoates, Alan; Chirgwin, Jacquie; Debled, Marc; Ejlertsen, Bent; et al, Various; Gelber, Richard D; Giobbie-Hurder, Anita; Goldhirsch, Aron; Price, Karen N.; Rabaglio, Manuela; Smith, Ian; School of Public Health: Public HealthTreatment adherence and its impact on disease-free survival in the breast international group 1-98 trial of tamoxifen and letrozole, alone and in sequence, Journal of Clinical Oncology, vol.34, 21, 2016,pp 2452-2459